Published in Medicine and Law Weekly, July 1st, 2005
According to the agreement, the licensee receives a worldwide non-exclusive research license of the Protein L gene as well as vectors and know-how of Protein L production under the Affitech patent rights for research and preclinical development work. Financial terms of the Agreement were not disclosed.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly